Purchase Order 75N95022P00079
Award Date 1/24/22
Potential Completion Date 1/25/27
Potential Value $285K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) was awarded a $214,111 firm fixed-price purchase order by the National Institute on Drug Abuse (NIDA) to provide maintenance support services for a Quantum GX MicroCT scanner during option period 3 of an existing contract. The work will be performed at the agency's facility in Bethesda, Maryland, with an ultimate completion date of March 31, 2023. This award represents a non-set-aside contract and reflects NIDA's continued...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract, valued at $915,668.54, is for the delivery of unspecified medical imaging products and services to NIDA. The award is not set aside for small businesses. As a prime contractor, Revvity Health Sciences has provided a variety of medical devices...
- This is a federal contract award to Revvity Health Sciences, Inc., doing business as PerkinElmer Inc., by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH). The $79,747.20 firm-fixed-price purchase order is for the provision and maintenance of an IVIS Lumina small animal imaging system. The contract has a period of performance through December 31, 2025. There is no set-aside designation, indicating...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on September 26, 2016. The contract has a ceiling value of $320,095.60 and a completion date of January 30, 2017. The contract was not set aside for any specific business type. Revvity Health Sciences, a for-profit manufacturer, will provide medical...
- The National Institute on Drug Abuse awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on July 14, 2026, for a Revvity Signature Service Plan covering a Celigo 5C automated cell imaging system, with a firm fixed price ceiling of $18,290.00 and an ultimate completion date of July 13, 2027. Performance occurs at Bethesda, Maryland. The order procures preventative maintenance and service coverage for specialized laboratory instrumentation, consistent...
- The National Institute on Drug Abuse (NIDA) awarded a $20,929 firm fixed-price purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on September 24, 2025, for a service agreement on a MicroBeta 2 scintillation counter. The contract, which extends through September 23, 2026, is designed to maintain the instrument in working condition at the Drug Dynamics Research Unit (DDRU) and Medicinal and Therapeutic Macromolecules Branch (MTMB) in Baltimore, Maryland,...
- This is a $459,410.40 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The contract is for an in vivo imaging (IVIS) and anesthesia system to be delivered to a place of performance in Baltimore, Maryland. The award does not have a set-aside designation. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract is for the purchase of an IVIS Lumina LT Instrument, Series III, 120V, which includes the trade-in of an existing IVIS 200 instrument. The contract has a ceiling value of $99,000.00 and was awarded on January 9, 2017, with a...
- Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $17,667 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to provide a one-year service agreement for a MicroBeta2 system with six detectors. The service agreement covers the period of September 24, 2023 through September 23, 2024 and will support the Department of Health and Human Services' biomedical research efforts at its Baltimore, Maryland...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $257,419.60 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the supply of a ViewLux HTS Imager from PerkinElmer Health Sciences Inc. This equipment will be used by the National Center for Advancing Translational Sciences (NCATS) to support its liquid dispensing high-throughput assays. The contract does not have a set-aside designation. Revvity Health Sciences,...